Tirzepatide patients report slightly higher rates of nausea in early weeks due to its more potent dual-receptor activation, though these symptoms typically resolve as your body adapts
Neurochem Int 128:94105 Davies M, Faerch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L et al (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
What is and is not included Included: medical provider consultation, compounded medication, B12, injection supplies (syringes, needles, alcohol swabs), Next Day Air shipping, and patient portal access for messaging your provider
This is where things become less predictable